CHAPTER 3 RECORD MANAGEMENT SYSTEM, DATA COLLECTION AND MONITORING
- 10Record management system
- 11Suspected adverse events
- 12Recording of adverse events
- 13Adverse event recording in the Union pharmacovigilance database
- 14Provision of additional data
- 15Post-marketing surveillance studies
- 16Risk management system
- 17Signal management process
- 18Monitoring benefit-risk balance
- 19Conclusion on the benefit-risk balance
- 20Communication
Source: EU legislation in force, consolidated versions and treaties (Cellar, Publications Office). Official publication. Reuse: Reuse authorised (Commission Decision 2011/833/EU).